USE OF PROSTAGLANDIN ANALOGS FOR TREATMENT OF CARDIAC CONDITIONS

Title:

USE OF PROSTAGLANDIN ANALOGS FOR TREATMENT OF CARDIAC CONDITIONS

Document Type and Number:

WIPO Patent Application WO2002060387

Kind Code:

A3

Abstract:

Methods to ameliorate cardiac conditions using PGF analogs which lack affinity for prostaglandin receptors is disclosed. Systemic administration of at least one PGF analog, preferably unoprostone isopropyl ester provides both therapeutic and prophylactic treatment for such conditions as congestive heart failure.

Inventors:

STEWART WILLIAM C (US)

Application Number:

PCT/US2002/003103

Publication Date:

March 06, 2003

Filing Date:

January 30, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

PHARMACEUTICAL RES CORP (US)
STEWART WILLIAM C (US)

International Classes:

A61K31/201; A61P9/00; (IPC1-7): A61K31/557; A61K31/215; A61K31/5575

Foreign References:

US5221763A	1993-06-22
US6235781B1	2001-05-22
US6211233B1	2001-04-03
US6329426B1	2001-12-11

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I kappa B KINASE (IKK)

Next Patent: ACYL SULFAMIDES FOR TREATMENT OF OBESITY, DIABETES AND LIPID DISORDERS